Reproducibility of fNIRS Parameters During Walking
REPROXY
1 other identifier
interventional
46
1 country
3
Brief Summary
Brain activation can be studied using the Functional Near InfraRed Spectroscopy (fNIRS). It was shown that CPF activation during walking and during dual task could be different in stroke patients and in healthy subjects. To date, fNIRS reliability is not completely established during walking and during dual task. Therefore, this study will examine the reproducibility of fNIRS parameters during simple walking and during dual task in healthy subjects and in stroke patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable stroke
Started Jun 2021
Typical duration for not_applicable stroke
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 15, 2021
CompletedFirst Posted
Study publicly available on registry
May 12, 2021
CompletedStudy Start
First participant enrolled
June 29, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 8, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 8, 2023
CompletedAugust 2, 2024
August 1, 2024
2.2 years
April 15, 2021
August 1, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Oxyhemoglobin (HbO) variations during simple walking and during dual task
HbO will be measured by the NIR spectrometry technique continuously at rest and during walking. This technique allows to measure the variations of HbO concentration by measuring the variations of light absorption by the explored tissues.
Day 0
Deoxyhemoglobin (HbR) variations during simple walking and during dual task
HbR will be measured by the NIR spectrometry technique continuously at rest and during walking. This technique allows to measure the variations of HbR concentration by measuring the variations of light absorption by the explored tissues.
Day 0
Secondary Outcomes (6)
Oxyhemoglobin (HbO) variations of acute stroke patients
Day 0
Deoxyhemoglobin (HbR) variations of acute stroke patients
Day 0
Oxyhemoglobin (HbO) variations of subacute stroke patients
Day 0
Deoxyhemoglobin (HbR) variations of subacute stroke patients
Day 0
Oxyhemoglobin (HbO) variations using different mathematical treatments.
Day 0
- +1 more secondary outcomes
Study Arms (1)
Functional Near-Infrared Spectroscopy (fNIRS) acquisitions
EXPERIMENTALThe hemodynamic response in CPF will be measured using an Octomon+ system (Artinis). Eight emission and two detector probes will be arranged on the participant's forehead.
Interventions
All participants will undergo Functional Near-Infrared Spectroscopy (fNIRS). The hemodynamic response in CPF will be measured using an Octomon+ system (Artinis). Eight emission and two detector probes will be arranged on the participant's forehead.
Eligibility Criteria
You may qualify if:
- Acute stroke group, subacute stroke group, and control group:
- Age 50 to 80 years
- Affiliated with a social security plan
- Able to walk 20 meters unassisted
- Acute Stroke and Subacute Stroke Group:
- Stroke onset less than 14 days (for the acute stroke group) or between 14 days and 6 months (for the subacute stroke group)
- Stroke located in the left or right middle cerebral artery.
You may not qualify if:
- Acute stroke group, subacute stroke group, and control group:
- Person under guardianship or curatorship
- Refusal to sign informed consent
- Known rheumatologic or cardiologic history
- Medication that alters the vigilance and may affect walking (high dose psychotropic drugs, antispastic drugs).
- Acute stroke group and subacute stroke group:
- History of symptomatic stroke
- Previous neurological disease limiting gait, aphasia or impaired cognitive function (mild cognitive dementia, Alzheimer's or Parkinson's disease)
- Ambulatory functional category \< 3
- Control group: neurological medical history
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Centre de Réadaptation Fonctionnelle et d'Appareillage Le Coteau
La Chapelle-Saint-Mesmin, France
Chu Limoges
Limoges, France
CHR Orléans
Orléans, 45067, France
Related Publications (4)
Hermand E, Tapie B, Dupuy O, Fraser S, Compagnat M, Salle JY, Daviet JC, Perrochon A. Prefrontal Cortex Activation During Dual Task With Increasing Cognitive Load in Subacute Stroke Patients: A Pilot Study. Front Aging Neurosci. 2019 Jul 2;11:160. doi: 10.3389/fnagi.2019.00160. eCollection 2019.
PMID: 31312136BACKGROUNDHawkins KA, Fox EJ, Daly JJ, Rose DK, Christou EA, McGuirk TE, Otzel DM, Butera KA, Chatterjee SA, Clark DJ. Prefrontal over-activation during walking in people with mobility deficits: Interpretation and functional implications. Hum Mov Sci. 2018 Jun;59:46-55. doi: 10.1016/j.humov.2018.03.010. Epub 2018 Mar 29.
PMID: 29604488BACKGROUNDHolden MK, Gill KM, Magliozzi MR, Nathan J, Piehl-Baker L. Clinical gait assessment in the neurologically impaired. Reliability and meaningfulness. Phys Ther. 1984 Jan;64(1):35-40. doi: 10.1093/ptj/64.1.35.
PMID: 6691052BACKGROUNDPelicioni PHS, Tijsma M, Lord SR, Menant J. Prefrontal cortical activation measured by fNIRS during walking: effects of age, disease and secondary task. PeerJ. 2019 May 3;7:e6833. doi: 10.7717/peerj.6833. eCollection 2019.
PMID: 31110922BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andreea AIGNATOAIE
CHR d'Orléans
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 15, 2021
First Posted
May 12, 2021
Study Start
June 29, 2021
Primary Completion
September 8, 2023
Study Completion
September 8, 2023
Last Updated
August 2, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share